English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/217918
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Neurological comorbidity is a predictor of death in Covid-19 disease: A cohort study on 576 patients

AuthorsGarcía-Azorín, David; Martínez-Pías, Enrique; Trigo, Javier; Hernández-Pérez, Isabel; Valle-Peñacoba, Gonzalo; Talavera, Blanca; Simón-Campo, Paula; Lera Alfonso, Mercedes de; Chavarría-Miranda, Alba; López-Sanz, Cristina; Gutiérrez-Sánchez, María; Martínez-Velasco, Elena; Pedraza, María; Sierra, Álvaro; Gómez-Vicente, Beatriz; Guerrero, Ángel ; Ezpeleta, David; Peñarrubia, María J.; Gómez-Herreras, José Ignacio; Bustamante-Munguira, Elena; Abad-Molina, Cristina; Orduña, Antonio; Ruiz-Martin, Guadalupe; Jiménez-Cuenca, Isabel; Juarros, Santiago; Pozo-Vegas, Carlos del; Dueñas-Gutierrez, Carlos; Prieto de Paula, José María; Cantón-Álvarez, Belén; Vicente, José Manuel; Arenillas, Juan F.
KeywordsSARS-CoV-2
Nervous system diseases
Stroke
Mortality
Prognosis
Issue Date7-Jul-2020
PublisherFrontiers Media
CitationFrontiers in Neurology 11: 781 (2020)
Abstract[Introduction]: Prognosis of Coronavirus disease 2019 (Covid-19) patients with vascular risk factors, and certain comorbidities is worse. The impact of chronic neurological disorders (CND) on prognosis is unclear. We evaluated if the presence of CND in Covid-19 patients is a predictor of a higher in-hospital mortality. As secondary endpoints, we analyzed the association between CND, Covid-19 severity, and laboratory abnormalities during admission.
[Methods]: Retrospective cohort study that included all the consecutive hospitalized patients with confirmed Covid-19 disease from March 8th to April 11th, 2020. The study setting was Hospital Clínico, tertiary academic hospital from Valladolid. CND was defined as those neurological conditions causing permanent disability. We assessed demography, clinical variables, Covid-19 severity, laboratory parameters and outcome. The primary endpoint was in-hospital all-cause mortality, evaluated by multivariate cox-regression log rank test. We analyzed the association between CND, covid-19 severity and laboratory abnormalities.
[Results]: We included 576 patients, 43.3% female, aged 67.2 years in mean. CND were present in 105 (18.3%) patients. Patients with CND were older, more disabled, had more vascular risk factors and comorbidities and fewer clinical symptoms of Covid-19. They presented 1.43 days earlier to the emergency department. Need of ventilation support was similar. Presence of CND was an independent predictor of death (HR 2.129, 95% CI: 1.382–3.280) but not a severer Covid-19 disease (OR: 1.75, 95% CI: 0.970–3.158). Frequency of laboratory abnormalities was similar, except for procalcitonin and INR.
[Conclusions]: The presence of CND is an independent predictor of mortality in hospitalized Covid-19 patients. That was not explained neither by a worse immune response to Covid-19 nor by differences in the level of care received by patients with CND.
Publisher version (URL)https://doi.org/10.3389/fneur.2020.00781
URIhttp://hdl.handle.net/10261/217918
DOIhttp://dx.doi.org/10.3389/fneur.2020.00781
ISSN1664-2295
Appears in Collections:(IBGM) Artículos
(VICYT) Colección Especial COVID-19
Files in This Item:
File Description SizeFormat 
fneur-11-00781.pdf557,69 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.